The global allergy immunotherapy market was valued at US$ 1.37 Bn in 2016 and is projected to register a cumulative annual growth rate (CAGR) of 10.7% from 2017 to 2025, according to a new report titled, “Allergy Immunotherapy Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”, published by Transparency Market Research (TMR) in April 2018. The ... Read more
The increased predisposition of individuals to allergies is expected to create an advantageous backdrop for the growth of the allergy immunotherapy market. Reports that assess the healthcare industry have been presented by Market Research Future, which creates reports on numerous industry verticals that examine the market progress and forecasts. The market is projected to achieve a CAGR of 10.85 % while accumulating revenues valued at USD 4,324.7 million by the end of the forecast period. ... Read more
Increasing incidences of allergies and inefficient treatment methodologies, such as pharmacotherapy, for controlling the occurrence rate of allergies are fuelling adoption of allergy immunotherapy, which is deemed as a designated cure for various types of allergies. A notable shift of patients and healthcare providers towards allergy immunotherapy has been observed, owing to its competency to change the course of the disease and improve the immunological resistance.
Global Allergy Immunotherapy Market Research Report: Information, by Allergy Type (Allergic Rhinitis, Allergic Asthma, Peanut Allergy, Cat Allergy and others), Treatment (Sublingual Immunotherapy, Subcutaneous Immunotherapy (SCIT) and Specific Immunotherapy (SIT)) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2023
Market Overview:
The global Allergy Immunotherapy market is estimated to be valued at US$ 2,116.0 million in 2022 and is expected to exhibit a CAGR of 9.3% over the forecast period 2022-2030. Allergy Immunotherapy is a medical treatment that helps alleviate allergic reactions by desensitizing the patient's immune system to specific allergens. This treatment involves exposing patients to gradually increasing doses of the allergen, allowing the body to build ... Read more
Allergy immunotherapy (AIT), also known as desensitization or hypo-sensitization, involves exposing people to gradually increasing doses of allergens to decrease the symptoms of hay fever and other allergic reactions. AIT helps treat pet dander, pollen, dust mites, and other allergies by altering the body's immune response and reducing sensitivity to these allergens.
Market key trends:
One of the major trends in the allergy immunotherapy market is the rise of sublingual ... Read more
Allergy immunotherapy, also known as desensitization or hypo-sensitization, is the treatment of allergic diseases through controlled administration of the substance to which the patient is allergic to. Allergen immunotherapy gradually lessens sensitivity to allergens and prevents or reduces adverse reactions. Allergy immunotherapy injections are given to treat allergies to substances such as pet dander, pollen, mold and insect venom.
The global Allergy Immunotherapy Market ... Read more
Allergy immunotherapy, also known as desensitization or hypo-sensitization, involves administering gradually increasing doses of an allergen to a person with allergic respiratory diseases such as allergic asthma, allergic rhinitis, and others. It is a medical treatment aimed at changing or modifying the immune system's response to allergen exposure. By exposing people to larger amounts of allergens over a period, immunotherapy reduces inflammation and symptoms upon re-exposure to ... Read more
Allergy immunotherapy aims to treat different types of allergies including food, drug, insect and environmental allergies. It involves exposing individuals to small amounts of allergen to induce tolerance and reduce sensitivity. Allergy immunotherapy products such as sublingual immunotherapy tablets and subcutaneous immunotherapy injections are used for desensitization.
The global Allergy Immunotherapy Market is estimated to be valued at US$ 2664.34 Mn in ... Read more
